Strados Labs is pioneering the future of respiratory health monitoring with its innovative RESP® Biosensor, the first FDA-cleared wearable stethoscope designed to detect coughs and wheezes. Based in Philadelphia and Atlanta, this cutting-edge technology allows for continuous monitoring of lung sounds, providing critical insights into patient health from hospital to home. With features like real-time data collection and secure storage in the cloud, Strados Labs is transforming how healthcare professionals manage chronic respiratory conditions such as asthma, chronic cough, and COPD.

Founded with a mission to "Make Every Breath Count," Strados Labs emphasizes the importance of personalized care through advanced technology. Their systems empower patients by continuously capturing lung sounds, facilitating better treatment decisions and improving outcomes. This local business not only enhances patient experiences but also supports healthcare providers by delivering clinically validated data that drives research and development in respiratory treatments. By choosing Strados Labs’ products, consumers are investing in local innovation that promotes healthier communities.